{
    "clinical_study": {
        "@rank": "102651", 
        "acronym": "AGENDA", 
        "biospec_descr": {
            "textblock": "Blood sample is taken for all patients underwent coronary angiogram after getting informed\n      consent, and stored in requested condition, for measuring serum levels of different kinds of\n      factors."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Blood sample is prospectively taken from consecutive patients underwent coronary angiogram\n      in our center, after getting informed consent from the patients. Serum level of advanced\n      glycation end products (AGEs) was measured and the clinical features of patients (including\n      angiographic results) were entered into our database. Clinical follow-up was performed for\n      all patients, and the relationship between AGEs and paitents' outcome were analyzed. Further\n      intervention will be adjusted according to the results,including clinical and basic research\n      in lab."
        }, 
        "brief_title": "Adavanced Glycated Endproducts and Development of CAD", 
        "condition": [
            "Atherosclerosis", 
            "Inflammation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atherosclerosis", 
                "Coronary Artery Disease", 
                "Inflammation"
            ]
        }, 
        "detailed_description": {
            "textblock": "Serum levels of HMGB1, HMGB2, ADAM10, etc. will be measured in lab and animal studies will\n      be designed to intervene the adverse interaction between abnormal serum concentration of\n      AGEs, etc. and worse clinical results."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients underwent coronary angiogram for suspected coronary artery disease and\n             potential percutaneous coronary intervention\n\n        Exclusion Criteria:\n\n          -  patients underwent coronary angiogram for other reasons, including pre-surgery\n             examination\n\n          -  patients with severe co-morbidity, and life expectancy less than one-year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "patients underwent coronary angiogram"
            }
        }, 
        "enrollment": {
            "#text": "10000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 13, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02089360", 
            "org_study_id": "RJH20140311"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Advanced glycation end product", 
            "coronary", 
            "atherosclerosis", 
            "inflammation", 
            "outcome"
        ], 
        "lastchanged_date": "March 14, 2014", 
        "location": {
            "contact": {
                "email": "rjlulin1965@163.com", 
                "last_name": "Lin Lu, PhD", 
                "phone": "86-21-64370045", 
                "phone_ext": "610910"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200025"
                }, 
                "name": "Ruijin Hospital, Shanghai Jiaotong University School of Medicine"
            }, 
            "investigator": {
                "last_name": "Lin Lu, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Study of Serum Level of Advanced Glycated Endproducts and Development of Coronary Atherosclerosis in Patients Undergoing Coronary Angiogram", 
        "other_outcome": {
            "description": "serum levels of AGEs will be measured and the relationship between clinical outcomes will be analyzed.", 
            "measure": "Serum level of AGEs", 
            "safety_issue": "No", 
            "time_frame": "baseline"
        }, 
        "overall_contact": {
            "email": "rjheart@gmail.com", 
            "last_name": "Qi Zhang, PhD", 
            "phone": "86-21-64370045", 
            "phone_ext": "665380"
        }, 
        "overall_contact_backup": {
            "email": "rjshenweifeng@gmail.com", 
            "last_name": "Wei Feng Shen, PhD", 
            "phone": "86-21-64370045", 
            "phone_ext": "665215"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "including death, occurrence of myocardial infarction, and coronary revascularization", 
            "measure": "MACE", 
            "safety_issue": "No", 
            "time_frame": "5-year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02089360"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shanghai Jiao Tong University School of Medicine", 
            "investigator_full_name": "Zhang Qi, MD", 
            "investigator_title": "Director, Cardiac Catheterization Lab", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "repeated coronary angiogram in patients with symptom aggravation or occurrence of myocardial infarction, to evaluate the progression of coronary lesions, comparing to the baseline results.", 
            "measure": "progression in coronary atherosclerosis", 
            "safety_issue": "No", 
            "time_frame": "5-year"
        }, 
        "source": "Shanghai Jiao Tong University School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai Jiao Tong University School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "5 Years", 
        "verification_date": "March 2014"
    }
}